BDX Becton Dickinson
NYSE · SEC CIK 10795 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $2.78M 21 sales by 5 insiders
- Filings on record
- 294 since 2021-08-04, latest 2026-09-03 19:24
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Polen Thomas E Jr | COB, CEO, Pres, Dir | — | $1.17M |
| Garrison Michael David | EVP, Pres Med.Essntl, BioPharm | — | $784.2K |
| Goette Roland | EVP, Pres, EMEA | — | $440.9K |
| SCOTT BERTRAM L | Dir | — | $212.3K |
| Feld Michael | EVP, Pres, Life Sciences | — | $167.4K |
| Menziuso Peter | EVP, Pres, BDI | — | — |
| Roque Vitor | Interim CFO | — | — |
| Spikner Pamela L. | SVPController, Chief Acct Off | — | — |
| Shan David | EVP, Chief ISC Off | — | — |
| Waldstreicher Joanne | Dir | — | — |
Transactions 334
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-11-30 | 2021-11-26 | BDX | Campion Simon D | EVP, Segment Pres | A - Grant | $0.00 | +2,775 | 9,461 | +42% | $0 |
| D | 2021-11-30 | 2021-11-26 | BDX | Campion Simon D | EVP, Segment Pres | F - Tax | $0.00 | -650 | 8,811 | -7% | $0 |
| 2021-11-30 | 2021-11-26 | BDX | Lim James C | EVP | A - Grant | $0.00 | +893 | 20.7K | +5% | $0 | |
| D | 2021-11-30 | 2021-11-26 | BDX | Hickey David | EVP, Pres, Life Sciences | A - Grant | $0.00 | +1,473 | 5,059 | +41% | $0 |
| D | 2021-11-30 | 2021-11-26 | BDX | Khichi Samrat S. | EVP, GC | F - Tax | $0.00 | -681 | 4,389 | -13% | $0 |
| DM | 2021-11-30 | 2021-11-26 | BDX | Khichi Samrat S. | EVP, GC | A - Grant | $0.00 | +2,904 | 5,070 | +134% | $0 |
| D | 2021-11-30 | 2021-11-26 | BDX | Mas Ribo Alberto | EVP, Pres, Life Sciences | F - Tax | $0.00 | -798 | 9,546 | -8% | $0 |
| DM | 2021-11-30 | 2021-11-26 | BDX | Mas Ribo Alberto | EVP, Pres, Life Sciences | A - Grant | $0.00 | +3,802 | 11.7K | +48% | $0 |
| DM | 2021-11-30 | 2021-11-26 | BDX | Polen Thomas E Jr | EVP | A - Grant | $0.00 | +13.4K | 20.2K | +195% | $0 |
| D | 2021-11-30 | 2021-11-26 | BDX | Polen Thomas E Jr | EVP | F - Tax | $0.00 | -1,913 | 18.3K | -9% | $0 |
| D | 2021-11-30 | 2021-11-26 | BDX | Ezell Antoine C | EVP, Pres, CMO, NA | A - Grant | $0.00 | +758 | 8,211 | +10% | $0 |
| DM | 2021-11-30 | 2021-11-26 | BDX | Goette Roland | EVP, Pres, EMEA | A - Grant | $0.00 | +937 | 9,685 | +11% | $0 |
| D | 2021-11-30 | 2021-11-26 | BDX | Goette Roland | EVP, Pres, EMEA | F - Tax | $0.00 | -31 | 9,654 | -0.3% | $0 |
| DM | 2021-11-30 | 2021-11-26 | BDX | Larson Betty D | CHRO, EVP HR | A - Grant | $0.00 | +2,656 | 7,428 | +56% | $0 |
| D | 2021-11-30 | 2021-11-26 | BDX | Larson Betty D | CHRO, EVP HR | F - Tax | $0.00 | -580 | 6,848 | -8% | $0 |
| DM | 2021-11-30 | 2021-11-26 | BDX | Spoerel Thomas J | VP Ctrl, Chief Acct Off | A - Grant | $0.00 | +489 | 1,220 | +67% | $0 |
| D | 2021-11-30 | 2021-11-26 | BDX | Spoerel Thomas J | VP Ctrl, Chief Acct Off | F - Tax | $0.00 | -195 | 1,025 | -16% | $0 |
| D | 2021-11-18 | 2021-11-16 | BDX | Goette Roland | EVP, Pres, EMEA | F - Tax | $244.11 | -1,914 | 9,373 | -17% | -$467.2K |
| D | 2021-11-18 | 2021-11-16 | BDX | Goette Roland | EVP, Pres, EMEA | M - OptEx | $72.12 | +3,055 | 11.3K | +37% | +$220.3K |
| 2021-10-25 | 2021-10-21 | BDX | Byington Carrie L | Dir | A - Grant | $0.00 | +221 | 221 | New | $0 | |
| 2021-09-08 | 2021-09-07 | BDX | DelOrefice Christopher | EVP, CFO | A - Grant | $0.00 | +4,359 | 4,359 | New | $0 | |
| 2021-09-08 | 2021-09-08 | BDX | RIMEL REBECCA W | Dir | S - Sale | $260.00 | -500 | 10.6K | -4% | -$130.0K | |
| 2021-09-08 | 2021-09-08 | BDX | Hickey David | EVP, Pres, Life Sciences | S - Sale | $260.00 | -500 | 3,586 | -12% | -$130.0K | |
| 2021-09-08 | 2021-09-08 | BDX | Spoerel Thomas J | VP Ctrl, Chief Acct Off | S - Sale | $260.00 | -267 | 1,018 | -21% | -$69.4K | |
| D | 2021-09-07 | 2021-09-03 | BDX | Lim James C | EVP | M - OptEx | $134.73 | +14.6K | 34.4K | +74% | +$1.96M |
| D | 2021-09-07 | 2021-09-03 | BDX | Lim James C | EVP | D - Sale to Iss | $257.44 | -7,628 | 26.7K | -22% | -$1.96M |
| D | 2021-09-07 | 2021-09-03 | BDX | Lim James C | EVP | S - Sale+OE | $257.44 | -6,956 | 19.8K | -26% | -$1.79M |
| 2021-09-07 | 2021-09-04 | BDX | Hickey David | EVP, Pres, Life Sciences | F - Tax | $0.00 | -268 | 4,086 | -6% | $0 | |
| 2021-09-03 | 2021-09-02 | BDX | RIMEL REBECCA W | Dir | S - Sale | $254.00 | -244 | 11.6K | -2% | -$62.0K | |
| 2021-09-03 | 2021-09-03 | BDX | RIMEL REBECCA W | Dir | S - Sale | $257.10 | -500 | 11.1K | -4% | -$128.6K | |
| 2021-08-31 | 2021-08-30 | BDX | RIMEL REBECCA W | Dir | S - Sale | $252.00 | -207 | 11.9K | -2% | -$52.2K | |
| 2021-08-18 | 2021-08-17 | BDX | RIMEL REBECCA W | Dir | S - Sale | $252.00 | -207 | 12.1K | -2% | -$52.2K | |
| 2021-08-18 | 2021-08-18 | BDX | Fraser Claire | Dir | S - Sale | $251.58 | -387 | 20.2K | -2% | -$97.4K | |
| 2021-08-09 | 2021-08-06 | BDX | Spoerel Thomas J | VP Ctrl, Chief Acct Off | S - Sale | $242.30 | -266 | 1,285 | -17% | -$64.5K |
Purchase Sale Sale after option exercise All abbreviations